Insider resale notice: common stock sale scheduled

Issuer files a Form 144 notice relating to proposed resale of common stock.

Rhea-AI Filing Summary

Issuer files a Form 144 notice relating to proposed resale of common stock. The filing lists 88,958 shares identified for sale on 04/30/2026, including option-derived lots of 65,625 and 23,333 shares. The filing also reports three open-market sales by Mark D. Eisner totaling 5,594 shares in February 2026 with proceeds shown.

Key Figures

Total shares identified for sale: 88,958 shares Option-derived lot 1: 65,625 shares Option-derived lot 2: 23,333 shares +4 more

7 metrics

Total shares identified for sale 88,958 shares listed on Form 144 for 04/30/2026

Option-derived lot 1 65,625 shares Option granted — sale listed for 04/30/2026

Option-derived lot 2 23,333 shares Option granted — sale listed for 04/30/2026

Shares sold 02/23/2026 2,089 shares Sale by Mark D. Eisner; proceeds $15,568.90

Shares sold 02/24/2026 1,616 shares Sale by Mark D. Eisner; proceeds $15,404.68

Shares sold 02/25/2026 1,889 shares Sale by Mark D. Eisner; proceeds $18,549.98

Recent sales total (Feb 2026) 5,594 shares Aggregate of three reported February 2026 sales by Mark D. Eisner

Key Terms

Form 144, Option Granted, Cash Common

3 terms

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Option Granted financial

"Option Granted - 07/15/2024"

Cash Common financial

"04/30/2026 | Cash Common"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does VIR's Form 144 say about shares to be sold?

The filing lists 88,958 shares identified for sale on 04/30/2026. It includes two option-derived lots of 65,625 and 23,333 shares that are noted as to be sold by cash exercise.

Who reported recent sales in the Form 144 for VIR?

The filing shows three open-market sales by Mark D. Eisner in February 2026 totaling 5,594 shares (2,089; 1,616; 1,889), with cash proceeds recorded for each transaction.

When are the scheduled sales in VIR's Form 144 expected to occur?

The identified transactions are scheduled for 04/30/2026, the date listed next to the 65,625-share and 23,333-share option-derived lots and correlated sale entries on the form.

Does the Form 144 disclose proceeds from recent transactions for VIR?

Yes. The three reported February 2026 sales by Mark D. Eisner show proceeds of $15,568.90, $15,404.68, and $18,549.98 respectively, linked to the share counts provided.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/30/2026 - 09:55 AM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001834161
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Vir Biotechnology, Inc.
SEC File Number	001-39083
Address of Issuer	1800 OWENS STREET SUITE 900 SAN FRANCISCO CALIFORNIA 94158
Phone	415-906-4324
Name of Person for Whose Account the Securities are To Be Sold	Eisner Mark
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Former Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	88958	916267.40	139517278	04/30/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/30/2026	Option Granted - 07/15/2024	Issuer			65625	04/30/2026	Cash
Common	04/30/2026	Option Granted - 02/22/2025	Issuer			23333	04/30/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Mark D. Eisner 1800 Owens Street Suite 900 San Francisco CA 94158	Common	02/23/2026	2089	15568.90
Mark D. Eisner 1800 Owens Street Suite 900 San Francisco CA 94158	Common	02/24/2026	1616	15404.68
Mark D. Eisner 1800 Owens Street Suite 900 San Francisco CA 94158	Common	02/25/2026	1889	18549.98

144: Remarks and Signature

Remarks
Date of Notice	04/30/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gary Redman, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Mark D. Eisner
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)